Study on the Brain Network of Angelman Syndrome

Status Completed

Clinical Trial Summary

The aims of study on Angelman syndrome: 1. Establish the Angelman syndrome database 2. Explore the brain Network of Angelman Syndrome Based on Multi-modal Brain Image and Neural-EEG Data

Clinical Trial Description

1. The participants recruitment: from Chinese Angelman Syndrome Patients group (Angelhome : angelman225@126.com) and Children's Hospital of Fudan University. 2. Fistly all participants had clinically and molecularly confirmed as Angelman syndrome . All participants should entry the online questionnaries and carified by telephone or on site . All the information will be recorded in the Angelman syndrome database. Investigators will analyze and summarize the relationship of phenotype and genotype(n=200). 3. Participants who assigned the informed consent and will undergo the brain MRI inspection and Neural-EEG recording in the Children's Hospital of Fudan University. The healthy age- and sex-matched control participants will enrolled in the same hospital. The Investigators will explore the brain morphology and electrophysiological alterations and for Angelman syndrome (AS) children among the different genotypes（n=200）. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03358823
Study type	Observational [Patient Registry]
Source	Fudan University
Contact
Status	Completed
Phase
Start date	May 20, 2017
Completion date	May 20, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05293184` - The Global Angelman Syndrome Registry
Completed	`NCT00004351` - Study of Phenotype and Genotype Correlations in Patients With Contiguous Gene Deletion Syndromes	N/A
Enrolling by invitation	`NCT06139172` - Promoting Prosocial Behavior in Syndromic Intellectual and Developmental Disabilities	N/A
Enrolling by invitation	`NCT03655223` - Early Check: Expanded Screening in Newborns
Recruiting	`NCT06229769` - Natural History Study for Patients With Angelman Syndrome
Enrolling by invitation	`NCT03836300` - Parent-Infant Inter(X)Action Intervention (PIXI)	N/A
Completed	`NCT03235037` - Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome	N/A
Recruiting	`NCT05100810` - Angelman Syndrome Natural History Study-FAST UK
Completed	`NCT03644693` - Nutritional Formulation for Angelman Syndrome	N/A
Recruiting	`NCT06337383` - Study of the Prevalence of Autistic Traits in Angelman Syndrome
Recruiting	`NCT05945576` - IDMet (RaDiCo Cohort) (RaDiCo-IDMet)
Completed	`NCT02670694` - Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW	N/A
Recruiting	`NCT04768803` - Ghrelin in Patients With a Rare Disease Associated With Intellectual Disability, and Hyperphagia, and/or Overweight, and/or Obesity
Recruiting	`NCT05630066` - Study to Investigate the Pharmacokinetics and Safety and to Provide Proof of Mechanism of Alogabat in Children and Adolescents Aged 5-17 Years With Angelman Syndrome (AS) With Deletion Genotype.	Phase 2
Completed	`NCT00348933` - Dietary Supplements for the Treatment of Angelman Syndrome	N/A
Recruiting	`NCT05011851` - An Open-Label Study of the Safety, Tolerability, and Pharmacokinetics of Oral NNZ-2591 in Angelman Syndrome	Phase 2
Terminated	`NCT03882918` - An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome	Phase 3
Completed	`NCT02996305` - A Study in Adults and Adolescents With Angelman Syndrome (STARS)	Phase 2
Completed	`NCT02056665` - Study to Evaluate the Efficacy and Safety of Minocycline in Angelman Syndrome	Phase 2
Completed	`NCT01281475` - A Trial of Levodopa in Angelman Syndrome	Phase 2/Phase 3